Squamous cell lung cancer: genomic evolution and personalized therapy
Objective. To review the state-of-the-art in relation to the current information on squamous cell lung cancer (SCLC). We describe the genetic anomalies reported, their effect, and finally the most promising therapeutic agents. Materials and methods. We reviewed published articles in peer-reviewed j...
Saved in:
Main Authors: | Andrés F Cardona (Author), Luisa Ricaurte (Author), Zyanya Lucia Zatarain-Barrón (Author), Oscar Arrieta (Author) |
---|---|
Format: | Book |
Published: |
Instituto Nacional de Salud Pública,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Access to lung cancer therapy in the Mexican population: Opportunities for reducing inequity within the health system
by: Raquel Gerson, et al.
Published: (2019) -
Characteristics of non-small cell lung cancer: Differences by sex and hormonal status in a Mexican population
by: Vianey Rodríguez-Lara, et al.
Published: (2019) -
Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
by: Pedro Barrios-Bernal, et al.
Published: (2022) -
Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report
by: Licheng Wu, et al.
Published: (2020) -
Genomic and transcriptional characterization of early esophageal squamous cell carcinoma
by: Jingjing Zhao, et al.
Published: (2023)